DOJ Probe into Andreessen Horowitz Signals Regulatory Peril for Multi-Stage VCs

The Department of Justice's ongoing investigation into Andreessen Horowitz (a16z) over potential interlocking directorates marks a watershed moment for venture capital governance. The federal probe, which has reportedly been active for nearly a year, centers on board seats held by co-founder Ben Horowitz at Databricks and general partner Martin Casado at Fivetran. As these two data-focused portfolio companies have increasingly grown into direct competitors, the arrangement has drawn antitrust scrutiny under Section 8 of the Clayton Act, which prohibits the same person or entity from serving as a director of competing corporations.

Historically, Section 8 enforcement was almost exclusively the domain of mature public markets. However, as capital concentration in private tech intensifies—with 250 companies achieving unicorn status in the first eight months of 2026 alone—the regulatory spotlight has shifted. Hyper-competitive fundraising dynamics, exemplified by startups like AI accounting platform Rillet raising 100 million dollars in a matter of days, have concentrated late-stage market share among a select group of elite institutional investors. For multi-stage venture firms, backing multiple players in the same sector is often a deliberate strategy to capture market upside, but it now carries significant antitrust liabilities.

The strategic implications for elite venture firms are immediate and severe. To avoid antitrust litigation, firms may be forced to proactively relinquish board seats, transitioning partners to non-voting observer roles or abandoning governance rights altogether. This shift fundamentally alters the venture value proposition. Board seats are not merely vanity metrics; they are critical mechanisms for protecting LP capital, steering corporate strategy, and securing proprietary market intelligence. Losing these seats weakens a firm's influence over its most valuable late-stage assets.

For founders and limited partners, the probe introduces a new layer of friction. Founders must now weigh the prestige of a tier-one lead investor against the risk that the firm's partners may be forced off their board due to portfolio conflicts. Meanwhile, LPs—already cautious in a sluggish exit market—must evaluate whether their fund managers are exposed to regulatory liabilities that could disrupt portfolio management or delay liquidity events. As the DOJ signals that private tech ecosystems are no longer exempt from antitrust enforcement, the era of the omnipotent, multi-board venture capitalist faces its steepest challenge yet.